Cui Jiewei, Zhou Minjuan, Li Ying, Liang Zhixin, Li Yanqin, Yu Ling, Liu Yang, Liang Yuan, Chen Liangan, Yang Changxi
Department of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing, China.
Laser Institute, Qilu University of Technology (Shandong Academy of Sciences), Qingdao, China.
Front Cell Infect Microbiol. 2021 May 31;11:665241. doi: 10.3389/fcimb.2021.665241. eCollection 2021.
() is one of the most common clinical pathogenic bacteria with strong pathogenicity and usually leads to various suppurative infections with high fatality. Traditional bacterial culture for the detection of is prone to diagnosis and antimicrobial treatment delays because of its long-time consumption and low sensitivity. In this study, we successfully developed a quantum dots immunofluorescence biosensor for detection. The biosensor combined the advantages of biosensors with the high specificity of antigen-antibody immune interactions and the high sensitivity and stability of quantum dots fluorescence. The results demonstrated that the biosensor possessed high specificity and high sensitivity for detection. The detection limit of reached 1 × 10 CFU/ml or even 1 × 10 CFU/ml, and moreover, the fluorescence intensity had a significant positive linear correlation relationship with the logarithm of the concentration in the range of 10-10 CFU/ml (correlation coefficient = 0.9731, = 0.011). A specificity experiment showed that this biosensor could effectively distinguish (1 × 10 CFU/ml and above) from other common pathogenic (non-) bacteria in nosocomial infections, such as , , and . Additionally, the whole detection procedure spent only 2 h. In addition, the biosensor in this study may not be affected by the interference of the biofilm or other secretions since the clinical biological specimens are need to be fully liquefied to digest and dissolve viscous secretions such as biofilms before the detection procedure of the biosensor in this study. In conclusion, the biosensor could meet the need for rapid and accurate detection for clinical application.
()是最常见的临床病原菌之一,致病性强,通常导致各种化脓性感染,病死率高。传统的用于检测()的细菌培养法由于耗时久且灵敏度低,容易导致诊断和抗菌治疗延迟。在本研究中,我们成功开发了一种用于检测()的量子点免疫荧光生物传感器。该生物传感器结合了生物传感器的优点以及抗原 - 抗体免疫相互作用的高特异性和量子点荧光的高灵敏度与稳定性。结果表明,该生物传感器对()检测具有高特异性和高灵敏度。()的检测限达到1×10 CFU/ml甚至1×10 CFU/ml,而且在10 - 10 CFU/ml范围内,荧光强度与()浓度的对数具有显著的正线性相关关系(相关系数 = 0.9731, = 0.011)。特异性实验表明,该生物传感器能够有效区分()(1×10 CFU/ml及以上)与医院感染中其他常见的致病性(非)细菌,如()、()、()和()。此外,整个检测过程仅需2小时。另外,由于在本研究的生物传感器检测程序之前,临床生物标本需要充分液化以消化和溶解诸如生物膜等粘性分泌物,所以本研究中的生物传感器可能不受生物膜或其他分泌物干扰的影响。总之,该生物传感器能够满足临床应用中对()进行快速准确检测的需求。